These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The current use of botulinum toxin. Mahant N; Clouston PD; Lorentz IT J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658 [TBL] [Abstract][Full Text] [Related]
23. Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin. Lees AJ; Turjanski N; Rivest J; Whurr R; Lorch M; Brookes G J Neurol; 1992 Jan; 239(1):1-4. PubMed ID: 1541963 [TBL] [Abstract][Full Text] [Related]
24. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm. Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703 [TBL] [Abstract][Full Text] [Related]
25. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences. Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088 [TBL] [Abstract][Full Text] [Related]
26. [Own experience with botulinum treatment of dystonia]. Domzał T Neurol Neurochir Pol; 1995; 29(4):481-8. PubMed ID: 8544926 [TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin in movement disorders. Papapetropoulos S; Singer C Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic application of botulinum toxin. Hambleton D J Med Microbiol; 1993 Oct; 39(4):243-5. PubMed ID: 8411083 [No Abstract] [Full Text] [Related]
30. Botulinum toxin: a dreaded toxin for use in human being. Ghosh B; Das SK J Indian Med Assoc; 2002 Oct; 100(10):607-8, 610-2, 614. PubMed ID: 12452515 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of movement disorders using botulinum toxin]. Burgunder JM Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387 [TBL] [Abstract][Full Text] [Related]
32. [Indications for botulinum toxin in neurology]. Ghika J; Küntzer T; Regli F Rev Med Suisse Romande; 1994 Jun; 114(6):551-5. PubMed ID: 8047771 [No Abstract] [Full Text] [Related]
33. [Clinical application of botulinum toxin]. Mezaki T Brain Nerve; 2011 Jul; 63(7):785-94. PubMed ID: 21747149 [TBL] [Abstract][Full Text] [Related]
34. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A. Greene PE; Fahn S Mov Disord; 1993 Oct; 8(4):479-83. PubMed ID: 8232357 [TBL] [Abstract][Full Text] [Related]
35. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment]. Domzał TM Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249 [TBL] [Abstract][Full Text] [Related]
36. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A]. Cardoso F Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166 [TBL] [Abstract][Full Text] [Related]
37. [Botulism toxin in practice]. Durand A; Serment G Ann Readapt Med Phys; 2003 Jul; 46(6):386-8. PubMed ID: 12928147 [TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm. Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461 [TBL] [Abstract][Full Text] [Related]
39. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553 [TBL] [Abstract][Full Text] [Related]
40. Costs of treating dystonias and hemifacial spasm with botulinum toxin A. Dodel RC; Kirchner A; Koehne-Volland R; Künig G; Ceballos-Baumann A; Naumann M; Brashear A; Richter HP; Szucs TD; Oertel WH Pharmacoeconomics; 1997 Dec; 12(6):695-706. PubMed ID: 10175981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]